Radiation boost for cervical cancer: SABR vs brachytherapy
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial compares two types of radiation boost therapy for locally advanced cervical cancer: a newer, precise type called SABR versus the standard brachytherapy. The goal is to see if SABR works as well or better with fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cervical cancer stage IB3, IIA, IIB, IIIA, or IIIC1 (locally advanced).
- The cancer type is squamous cell, adenosquamous, or adenocarcinoma (common types).
- You have not had any prior treatment for cervical cancer.
- You are able to receive the chemotherapy drug cisplatin.
- You are generally healthy enough for treatment (WHO performance status 0–2).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests adding an extra, targeted radiation dose directly into the tumor for women with bulky cervical cancer, alongside standard chemoradiation. It aims to improve local control without increasing side effects.
This trial tests a feasibility (“can it be done safely?”) approach that delivers radiation in a shorter schedule for some cervical cancer patients. It also uses weekly cisplatin chemotherapy and includes a radiation procedure called brachytherapy to improve treatment effectiveness.
This trial is testing a combination of standard chemotherapy and radiation delivered to the pelvis, followed by an internal radiation treatment guided by CT scans. The goal is to improve treatment for locally advanced cervical cancer while potentially reducing side effects.
This trial tests a precise, high-dose radiation treatment (called SABR) for older women with early-stage breast cancer who choose not to have surgery. It aims to control the tumor with fewer side effects and may be an option if you have a small, ER+, HER2- tumor that hasn't spread to lymph nodes.
This trial tests a new way of delivering radiation therapy (brachytherapy) combined with chemotherapy for advanced cervical cancer. The goal is to see if a faster, more intense radiation schedule is safe and effective.
This trial studies whether using CT scans to plan radiation treatment (brachytherapy) is as good as using MRI scans, for cervical cancer. If you join, you may receive standard radiation and chemotherapy, and the imaging method will be chosen randomly.
Hear when a new Uterine Cervical Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.